Viral Hepatitis Coinfection
Resources: 43
Barriers to Curing Hepatitis C Virus among Coinfected People with HIV Infographic
This infographic addresses some of the barriers to curing HCV infection among coinfected people with HIV. It highlights provider, patient, and financial/systems barriers; provides information for HCV...
HIV/HCV Co-infection: An AETC National Curriculum
The goal of this project is to provide an evidence-based online curriculum for health care providers and trainers of health care providers to increase their knowledge on human immunodeficiency virus (...
Passport to Cure
Passport to Cure is an interactive patient engagement brochure. It helps clients track clinic visits and monitor their HCV treatment progress to achieve a sustained viral response. It folds down to a...
In Brief: HIV and Hepatitis News
In Brief consists of concise summaries of the latest information about HIV, hepatitis, and health disparities organized by topic for easy review. Each item includes links to source materials and resou...
HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C
Comprehensive guidelines, including:
- Testing, Evaluation, and Monitoring
- Management of Treatment-Naive Patients
- Management of Treatment-Experienced Patients
- Unique Populations, including patients with HIV...
Hep C Free Postcard
The Hep C Free postcard is designed to celebrate and acknowledge patient success when hepatitis C viral suppression is achieved. It also serves as a reminder of the risk factors that can lead to HCV r...
Flyer: Hepatitis C Screening and Treatment in People with HIV
This flyer was adapted from a similar resource developed by the New York Department of Health and Mental Hygiene. Providers can post this resource in their clinical setting as a quick reference tool f...
Myths about Providing HCV Treatment to People with HIV with Substance Use Disorder(s)
HCV treatment is recommended for ALL people with HCV, with rare exceptions1, and substance use is NOT a contraindication to HCV treatment. In people with active substance disorder, treatment of HCV re...
Health Maintenance Recommendations Brochure
This brochure provides information on the recommended vaccine schedules for people with HIV. The resource is upd...
Northeast/Caribbean AETC On-Demand Video Series
Northeast/Caribbean (NECA) AETC on-demand videos, lectures, and self-study modules courses are available for all healthcare providers including pharmacists & oral health providers. Register for ea...
Hepatitis C: Getting Cured Is Easier than Ever
This patient resource is designed to address the reluctance patients sometimes feel regarding hepatitis C treatment initiation based on past experiences with old hepatitis C treatment regimens. It exp...
Barriers to HCV Care among Persons of Color
Session facilitated by Lauren Brinkley-Rubinstein, PhD, Assistant Professor of Social Medicine
University of North Carolina at Chapel Hill
Webinar Objectives:
- Describe barriers to care among people of c...
Ending the HIV & HCV Epidemics: A Critical Role for Substance Use Providers
This slide set introduces substance use disorder providers to the issues of HIV and hepatitis C virus (HCV) screening and prevention, recognizing the important role that substance use disorder provide...
From Diagnosis to Treatment: How to Build an HCV Clinical Toolkit
This toolkit includes webinars, online trainings and resources for both providers and patients such as:
- HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis
- Facts and fictions of...
Hepatitis C Prescriber Toolkit
State-specific resources to assist providers in navigating health coverage requirements that may impact the prescription of hepatitis c treatment...
Direct-acting Antiviral (DAA) Prior Authorization Letter Templates
The AETC HIV Comorbidity Community of Practice and Learning has developed three generic (no specific pharmaceuticals identified) template letters for healthcare providers to use for prior authorizatio...
Hepatitis B Immunity in HIV: Case Vignette
Training slides reviewing cases of hep B immunity in people with HIV.
Hepatitis C Online
Hepatitis C Online is a free educational website from the University of Washington National Hepatitis Training Center. This project is funded by the Centers for Disease Control and Prevention (CDC).
Th...
Breaking the Chain of Infection: Series for Nurses in Corrections with Continuing Education
This series provides best practices and updates for HIV, viral hepatitis, mental health and STI treatment in the correctional setting.
Breaking the Chain of Infection: Nurses in Corrections Session 1
(R...
Prevention and Treatment of Hepatitis C Infection among People who Use Drugs
Training slides provide information about the importance of treating people with HCV who use drugs to eliminate hepatitis C as a public health threat, dispels common myths about HCV treatment among pe...
Isolated Hepatitis B Core Antibody in People with HIV Infection
Training slides define and review isolated hepatitis B core antibody, isolated anti-HBc, occult HBV infection and the clinical significance, and HBV immunizations, and considerations for people with H...
Hepatitis C Treatment Update
Training slides provide an epidemiology update, review new AASLD/IDSA practice guidelines, review what to do with treatment interruptions and discuss pregnancy and HCV therapy.
HIV Resource Library
New England AETC's HIV Resource Library is a compilation of curated resources and education packets on HIV, viral hepatitis, and related public health topics.
Each Library topic page is an organized li...
Clinically Relevant Drug Interactions with Direct Acting Antivirals (DAAs)
Training slides cover the basic pharmacokinetic properties of DAAs, review interactions between DAAs and antiretroviral medications and non-HIV medications, and how to modify treatment for HCV or HIV...
Treating Hepatitis C Among People who Use Drugs
Training slides review the epidemiology of hepatitis C (HCV) among people who use drugs, review treatment as prevention, dispel myths about HCV treatment among people who use drugs and discuss special...
Hepatitis C Toolkit Curriculum
The purpose of this training is to improve providers’ capacity to screen, medically manage, and provide advanced care for patients with hepatitis C virus (HCV).
Learning Objectives
- Identify risk factors...
Benefits of Sustained Virologic Response (SVR) Post Direct-acting Antiviral (DAA) Therapy
Training slides review the impact of SVR and the risk of diabetes in patients treated with DAAs for hepatitis C virus (HCV) compared to untreated patients, and discuss the impact of SVR on liver compl...
Treatment of HCV Genotype 3 in Patients with Cirrhosis
Training slides review the difference between HCV genotype 3 and other genotypes, and identify appropriate treatment options for patients with HCV genotype 3 and cirrhosis.
ConnQuER HepC App: Educational and Care Companion App
From New England AETC's Connecticut (CT) Regional Partner, the ConnQuER HepC App is useful for patients, case managers, and community health workers. It is designed to inform about the clinical condit...
HIV/HCV Molecular Cluster Detection
Training slides provide an overview of molecular cluster detection, the steps needed to incorporate molecular cluster detection into a comprehensive HIV/HCV cluster detection outbreak response plan, a...
Community-Based HIV and Viral Hepatitis Fellowship Evaluation: Results from a Qualitative Study
The New England AETC regional office recently published an article about the UMass Chan Medical School/NEAETC Community-Based HIV and Viral Hepatitis Fellowship. The purpose of this study was to ident...
National HIV Curriculum & Promotional Resources
The National HIV Curriculum (NHC) provides free, up-to-date content for clinicians to learn about HIV diagnosis, treatment, and prevention. The 37 lessons and corresponding question bank topics offer...
Ryan White HIV/AIDS Program (RWHAP) Clinical Conference
Each year HRSA's HIV/AIDS Bureau sponsors a conference for Ryan White Program clinicians to learn about advances in care and treatment. The AETC National Coordinating Resource Center and its partner,...
HIV and HCV Drug Interactions: Quick Guides for Clinicians
A collection of clinical guides regarding drug interactions of hepatitis C virus (HCV) direct-acting antivirals (DAAs) with other common primary care medications and HIV antiretrovirals.
AIDS Seminar - Current and Future Research in STI Vaccines
Description:
(Recorded 1/9/23)
More than one million sexually transmitted infections (STIs) are acquired every day worldwide. Untreated STIs have a significant impact on sexual and reproductive health a...
Management of HCV and HIV Coinfection
Training slides provide updates on HCV-HIV coinfection management including epidemiology, pre-treatment assessment, treatment options, recommendations, and outcomes for people coinfected with HCV and...
Hepatitis B Prevention: New Vaccines and the Boundaries of HBV Protection
Training slides review newer options for hepatitis B immunization and their seroprotective efficacy in key subpopulations, including people with HIV.
Hepatitis C in Connecticut: Racial and Ethnic Disparities in Prevalence, Treatment, and Cure Rates
Webinar recording covers the current prevalence of hepatitis C among key populations in CT, highlights diagnostic and management issues for hepatitis C, and reviews recent data on disparities in treat...
Management of Hepatitis B in People with HIV
Training slides learning objectives:
- Discuss hepatitis B Virus (HBV) epidemiology and current immunization recommendations and practices in people with HIV.
- Explain HBV serologic diagnosis in people wi...
HCV Treatment Interruptions: Stop Treatment or Keep Going?
Training slides learning objective include:
- Applying the guidance provided by the AASLD/IDSA on hepatitis C virus (HCV) direct-acting antiviral (DAA) treatment interruptions
- Identifying when patients s...
Hepatitis C: Drug-Drug Interactions
Training slides learning objections include:
- Understanding the mechanism of action for drug interactions with hepatitis C medications
- Recognizing which medications should be avoided in co-administration...
Corrections Video Series
Created in collaboration with Southeast AETC's South Carolina partner, this animated video series provides guides to basic HIV and HCV discussions. Its target audience is healthcare professionals who...
Resources: 5
HCV Pretreatment Evaluation
Objectives
- Describe how to evaluate likelihood of disease progression
- Discuss importance of and methods for staging liver disease
- Explain how to assess patient readiness for treatment
- Summarize key aspect...
Action Plan for the Prevention, Care, & Treatment of Viral Hepatitis
The National Viral Hepatitis Action Plan (2017-2020) [PDF - 84 pages] is our nation’s battle plan for fighting viral hepatitis in the United States. The updated plan outlines strategies to achieve fou...
CROI Update: HIV Co-Infections and Comorbidities
Training slides review various studies on HIV & COVID, tuberculosis, and hepatitis C.
CROI 2022 Highlights: HIV Co-infections
Training slides review highlights from CROI 2022 regarding HIV co-infections including tuberculosis, COVID-19, and hepatitis C.
HIV & Viral Hepatitis: Highlights from CROI 2022
Training slides recap some of the highlights presented at the 2022 Conference on Retroviruses and Opportunistic Infections (CROI) related to HIV & viral hepatitis.
Articles: 2
NCCC's Promising Practices & Pearls: Fibrosis Matters
Patients with chronic hepatitis C (CHC) should receive treatment with directly acting antivirals (DAAs) regardless of fibrosis stage. But does that mean that fibrosis is irrelevant? Absolutely not. Fibrosis remains a central concept in the care of patients with chronic liver disease, and patients wi...
NCCC's Promising Practices & Pearls: HCV Treatment Interruption
Case Summary
A 67-year-old cisgender male with chronic HCV mono-infection was seen for treatment evaluation. He had no history of prior HCV treatment, and initial assessment revealed genotype 1a and a fibrosis score of F3/F4. Direct-acting antiviral (DAA) therapy using 12-weeks of sofosbuvir/velpat...
- Sep 26Eliminating Hepatitis C Virus among People with HIV: Data to Care Approaches (Online)Tuesday, September 26, 2023 - 2:00pm EDT to Tuesday, September 26, 2023 - 3:00pm EDTEvent type:
- Oct 11Management and Treatment of Chronic Hepatitis C Infection (Online)Wednesday, October 11, 2023 - 12:00pm EDT to Wednesday, October 11, 2023 - 1:00pm EDTNew England AETCEvent type:
- Dec 32023 Ryan White HIV/AIDS Program (RWHAP) CLINICAL CONFERENCE (National, Oregon)Sunday, December 3, 2023 (All day) to Tuesday, December 5, 2023 (All day)AETC National Coordinating Resource CenterEvent type:
- May 22024 Latinx Conference on HIV/HCV/SUD (Texas)Thursday, May 2, 2024 (All day) to Saturday, May 4, 2024 (All day)South Central AETC, Valley AIDS CouncilEvent type:
- Mar 7CROI Update 2022 [Virtual] (Online)Monday, March 7, 2022 - 6:00pm EST to Monday, March 7, 2022 - 8:00pm ESTNew England AETCEvent type:
- May 19Hepatitis Testing Day (National)Friday, May 19, 2023 - 12:00am EDT to Friday, May 19, 2023 - 11:45pm EDTEvent type:
- Jul 25African American Hepatitis C Action Day (National)Tuesday, July 25, 2023 - 12:00am EDT to Tuesday, July 25, 2023 - 11:59pm EDTEvent type:
- Jul 28